Literature DB >> 33570721

Inadvertent nucleotide sequence alterations during mutagenesis: highlighting the vulnerabilities in mouse transgenic technology.

Anuran Ghosh1, Rituparna Chakrabarti1, Praphulla Chandra Shukla2.   

Abstract

In the last three decades, researchers have utilized genome engineering to alter the DNA sequence in the living cells of a plethora of organisms, ranging from plants, fishes, mice, to even humans. This has been conventionally achieved by using methodologies such as single nucleotide insertion/deletion in coding sequences, exon(s) deletion, mutations in the promoter region, introducing stop codon for protein truncation, and addition of foreign DNA for functional elucidation of genes. However, recent years have witnessed the advent of novel techniques that use programmable site-specific nucleases like CRISPR/Cas9, TALENs, ZFNs, Cre/loxP system, and gene trapping. These have revolutionized the field of experimental transgenesis as well as contributed to the existing knowledge base of classical genetics and gene mapping. Yet there are certain experimental/technological barriers that we have been unable to cross while creating genetically modified organisms. Firstly, while interfering with coding strands, we inadvertently change introns, antisense strands, and other non-coding elements of the gene and genome that play integral roles in the determination of cellular phenotype. These unintended modifications become critical because introns and other non-coding elements, although traditionally regarded as "junk DNA," have been found to play a major regulatory role in genetic pathways of several crucial cellular processes, development, homeostasis, and diseases. Secondly, post-insertion of transgene, non-coding RNAs are generated by host organism against the inserted foreign DNA or from the inserted transgene/construct against the host genes. The potential contribution of these non-coding RNAs to the resulting phenotype has not been considered. We aim to draw attention to these inherent flaws in the transgenic technology being employed to generate mutant mice and other model organisms. By overlooking these aspects of the whole gene and genetic makeup, perhaps our current understanding of gene function remains incomplete. Thus, it becomes important that, while using genetic engineering techniques to generate a mutant organism for a particular gene, we should carefully consider all the possible elements that may play a potential role in the resulting phenotype. This perspective highlights the commonly used mouse strains and the most probable associated complexities that have not been considered previously, resulting in possible limitations in the currently utilized transgenic technology. This work also warrants the use of already established mouse lines in further research.

Entities:  

Keywords:  Fidelity; Knockout; Non-coding; Transgenic

Year:  2021        PMID: 33570721      PMCID: PMC7877310          DOI: 10.1186/s43141-021-00130-5

Source DB:  PubMed          Journal:  J Genet Eng Biotechnol        ISSN: 1687-157X


  62 in total

1.  Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus.

Authors:  Paul B McCray; Lecia Pewe; Christine Wohlford-Lenane; Melissa Hickey; Lori Manzel; Lei Shi; Jason Netland; Hong Peng Jia; Carmen Halabi; Curt D Sigmund; David K Meyerholz; Patricia Kirby; Dwight C Look; Stanley Perlman
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

2.  An animal model for cystic fibrosis made by gene targeting.

Authors:  J N Snouwaert; K K Brigman; A M Latour; N N Malouf; R C Boucher; O Smithies; B H Koller
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

3.  Mice that express human interleukin-8 have increased mobilization of immature myeloid cells, which exacerbates inflammation and accelerates colon carcinogenesis.

Authors:  Samuel Asfaha; Alexander N Dubeykovskiy; Hiroyuki Tomita; Xiangdong Yang; Sarah Stokes; Wataru Shibata; Richard A Friedman; Hiroshi Ariyama; Zinaida A Dubeykovskaya; Sureshkumar Muthupalani; Russell Ericksen; Harold Frucht; James G Fox; Timothy C Wang
Journal:  Gastroenterology       Date:  2012-10-03       Impact factor: 22.682

4.  ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury.

Authors:  Chuanming Xu; Fei Wang; Yanting Chen; Shiying Xie; Danielle Sng; Bruno Reversade; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-16

Review 5.  Translatable gene therapy for lung cancer using Crispr CAS9-an exploratory review.

Authors:  Jishnu Nair; Abhishek Nair; Soundaram Veerappan; Dwaipayan Sen
Journal:  Cancer Gene Ther       Date:  2019-06-20       Impact factor: 5.987

Review 6.  Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements.

Authors:  Lucy W Barrett; Sue Fletcher; Steve D Wilton
Journal:  Cell Mol Life Sci       Date:  2012-04-27       Impact factor: 9.261

7.  YAP/TAZ direct commitment and maturation of lymph node fibroblastic reticular cells.

Authors:  Sung Yong Choi; Hosung Bae; Sun-Hye Jeong; Intae Park; Hyunsoo Cho; Seon Pyo Hong; Da-Hye Lee; Choong-Kun Lee; Jin-Sung Park; Sang Heon Suh; Jeongwoon Choi; Myung Jin Yang; Jeon Yeob Jang; Lucas Onder; Jeong Hwan Moon; Han-Sin Jeong; Ralf H Adams; Jin-Man Kim; Burkhard Ludewig; Joo-Hye Song; Dae-Sik Lim; Gou Young Koh
Journal:  Nat Commun       Date:  2020-01-24       Impact factor: 14.919

8.  Imprinted Cdkn1c genomic locus cell-autonomously promotes cell survival in cerebral cortex development.

Authors:  Susanne Laukoter; Robert Beattie; Florian M Pauler; Nicole Amberg; Keiichi I Nakayama; Simon Hippenmeyer
Journal:  Nat Commun       Date:  2020-01-10       Impact factor: 14.919

9.  The RNA-binding protein HuR is a negative regulator in adipogenesis.

Authors:  Diana Teh Chee Siang; Yen Ching Lim; Aung Maung Maung Kyaw; Khaing Nwe Win; Sook Yoong Chia; Ufuk Degirmenci; Xiang Hu; Bryan C Tan; Arcinas Camille Esther Walet; Lei Sun; Dan Xu
Journal:  Nat Commun       Date:  2020-01-10       Impact factor: 14.919

10.  ABCA1 Exerts Tumor-Suppressor Function in Myeloproliferative Neoplasms.

Authors:  Manon Viaud; Omar Abdel-Wahab; Julie Gall; Stoyan Ivanov; Rodolphe Guinamard; Sophie Sore; Johanna Merlin; Marion Ayrault; Emma Guilbaud; Arnaud Jacquel; Patrick Auberger; Nan Wang; Ross L Levine; Alan R Tall; Laurent Yvan-Charvet
Journal:  Cell Rep       Date:  2020-03-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.